Works matching IS 10837159 AND DT 2017 AND VI 22 AND IP 3

Results: 16

FDA Approval Summary: Nivolumab in Advanced Renal Cell Carcinoma After Anti-Angiogenic Therapy and Exploratory Predictive Biomarker Analysis.
Published in:
Oncologist, 2017, v. 22, n. 3, p. 311, doi. 10.1634/theoncologist.2016-0476
By:
- Xu, James Xunhai;
- Maher, V. Ellen;
- Zhang, Lijun;
- Tang, Shenghui;
- Sridhara, Rajeshwari;
- Ibrahim, Amna;
- Kim, Geoffrey;
- Pazdur, Richard
Publication type:
Article
Pediatric, Adolescent, and Young Adult Thyroid Carcinoma Harbors Frequent and Diverse Targetable Genomic Alterations, Including Kinase Fusions.
Published in:
Oncologist, 2017, v. 22, n. 3, p. 255, doi. 10.1634/theoncologist.2016-0279
By:
- Vanden Borre, Pierre;
- Schrock, Alexa B.;
- Anderson, Peter M.;
- Morris, John C.;
- Heilmann, Andreas M.;
- Holmes, Oliver;
- Wang, Kai;
- Johnson, Adrienne;
- Waguespack, Steven G.;
- Ou, Sai‐Hong Ignatius;
- Khan, Saad;
- Fung, Kar‐Ming;
- Stephens, Philip J.;
- Erlich, Rachel L.;
- Miller, Vincent A.;
- Ross, Jeffrey S.;
- Ali, Siraj M.
Publication type:
Article
Management of Cancer in the Older Age Person: An Approach to Complex Medical Decisions.
Published in:
Oncologist, 2017, v. 22, n. 3, p. 335, doi. 10.1634/theoncologist.2016-0276
By:
- Vallet‐Regí, María;
- Manzano, Miguel;
- Rodriguez‐Mañas, Leocadio;
- Checa López, Marta;
- Aapro, Matti;
- Balducci, Lodovico;
- Barbacid, Mariano;
- Guise, Theresa A.;
- Mena, Alfredo Carrato;
- Ortiz Romero, Pablo L.;
- Orellana, Manuel Ramírez;
- Mañas, Leocadio Rodríguez
Publication type:
Article
The Antiproliferative Role of Lanreotide in Controlling Growth of Neuroendocrine Tumors: A Systematic Review.
Published in:
Oncologist, 2017, v. 22, n. 3, p. 272, doi. 10.1634/theoncologist.2016-0305
By:
- Michael, Michael;
- Garcia‐Carbonero, Rocio;
- Weber, Matthias M.;
- Lombard‐Bohas, Catherine;
- Toumpanakis, Christos;
- Hicks, Rodney J.
Publication type:
Article
Randomized Phase II Study of Ramucirumab or Icrucumab in Combination with Capecitabine in Patients with Previously Treated Locally Advanced or Metastatic Breast Cancer.
Published in:
Oncologist, 2017, v. 22, n. 3, p. 245, doi. 10.1634/theoncologist.2016-0265
By:
- Vahdat, Linda T.;
- Layman, Rachel;
- Yardley, Denise A.;
- Gradishar, William;
- Salkeni, Mohamad A.;
- Joy, Anil Abraham;
- Garcia, Agustin A.;
- Ward, Patrick;
- Khatcheressian, James;
- Sparano, Joseph;
- Rodriguez, Gladys;
- Tang, Shande;
- Gao, Ling;
- Dalal, Rita P.;
- Kauh, John;
- Miller, Kathy
Publication type:
Article
Multidisciplinary Management of Breast Cancer During Pregnancy.
Published in:
Oncologist, 2017, v. 22, n. 3, p. 324, doi. 10.1634/theoncologist.2016-0208
By:
- Shachar, Shlomit Strulov;
- Gallagher, Kristalyn;
- McGuire, Kandace;
- Zagar, Timothy M.;
- Faso, Aimee;
- Muss, Hyman B.;
- Sweeting, Raeshall;
- Anders, Carey K.
Publication type:
Article
Survival Gains from First-Line Systemic Therapy in Metastatic Non-Small Cell Lung Cancer in the U.S., 1990-2015: Progress and Opportunities.
Published in:
Oncologist, 2017, v. 22, n. 3, p. 304, doi. 10.1634/theoncologist.2016-0253
By:
- Roth, Joshua A.;
- Goulart, Bernardo H. L.;
- Ravelo, Arliene;
- Kolkey, Holli;
- Ramsey, Scott D.
Publication type:
Article
Early Palliative Care Reduces End-of-Life Intensive Care Unit (ICU) Use but Not ICU Course in Patients with Advanced Cancer.
Published in:
Oncologist, 2017, v. 22, n. 3, p. 318, doi. 10.1634/theoncologist.2016-0227
By:
- Romano, Andrew M.;
- Gade, Kristine E.;
- Nielsen, Gradon;
- Havard, Robert;
- Harrison, James H.;
- Barclay, Josh;
- Stukenborg, George J.;
- Read, Paul W.;
- Blackhall, Leslie J.;
- Dillon, Patrick M.
Publication type:
Article
Population-Level Differences in Rectal Cancer Survival in Uninsured Patients Are Partially Explained by Differences in Treatment.
Published in:
Oncologist, 2017, v. 22, n. 3, p. 351, doi. 10.1634/theoncologist.2016-0274
By:
- Pulte, Dianne;
- Jansen, Lina;
- Brenner, Hermann
Publication type:
Article
The Use of Hyperbaric Oxygen for the Prevention and Management of Osteoradionecrosis of the Jaw: A Dana-Farber/Brigham and Women's Cancer Center Multidisciplinary Guideline.
Published in:
Oncologist, 2017, v. 22, n. 3, p. 343, doi. 10.1634/theoncologist.2016-0298
By:
- Sultan, Ahmed;
- Hanna, Glenn J.;
- Margalit, Danielle N.;
- Chau, Nicole;
- Goguen, Laura A.;
- Marty, Francisco M.;
- Rabinowits, Guilherme;
- Schoenfeld, Jonathan D.;
- Sonis, Stephen T.;
- Thomas, Tom;
- Tishler, Roy B.;
- Treister, Nathaniel S.;
- Villa, Alessandro;
- Woo, Sook‐Bin;
- Haddad, Robert;
- Mawardi, Hani
Publication type:
Article
Efficacy and Safety of FOLFIRI Regimen in Elderly Patients with Metastatic Colorectal or Gastric Cancer.
Published in:
Oncologist, 2017, v. 22, n. 3, p. 293, doi. 10.1634/theoncologist.2016-0166
By:
- Kim, Ji‐Won;
- Lee, Keun‐Wook;
- Kim, Kyu‐Pyo;
- Lee, Ju Hyun;
- Hong, Yong Sang;
- Kim, Jeong‐Eun;
- Kim, Sun Young;
- Park, Sook Ryun;
- Nam, Byung‐Ho;
- Cho, Sang‐Hee;
- Chung, Ik‐Joo;
- Park, Young Suk;
- Oh, Ho‐Suk;
- Lee, Myung‐Ah;
- Kang, Hye Jin;
- Park, Young Iee;
- Song, Eun‐Kee;
- Han, Hye Sook;
- Lee, Kyu Taeg;
- Shin, Dong Bok
Publication type:
Article
A Phase II, Randomized, Double-Blind, Placebo-Controlled Study of Simtuzumab in Combination with FOLFIRI for the Second-Line Treatment of Metastatic KRASMutant Colorectal Adenocarcinoma.
Published in:
Oncologist, 2017, v. 22, n. 3, p. 243, doi. 10.1634/theoncologist.2016-0479
By:
- Hecht, J. Randolph;
- Benson, Al B.;
- Vyushkov, Dmitry;
- Yang, Yingsi;
- Bendell, Johanna;
- Verma, Udit
Publication type:
Article
Gastroenteropancreatic Neuroendocrine Carcinomas: The NET G3 Subcategory Is a Reality.
Published in:
2017
By:
- Fazio, Nicola;
- Milione, Massimo
Publication type:
Letter to the Editor
A Phase II Randomized, Double-Blind, Placebo-Controlled Study of Simtuzumab or Placebo in Combination with Gemcitabine for the First-Line Treatment of Pancreatic Adenocarcinoma.
Published in:
Oncologist, 2017, v. 22, n. 3, p. 241, doi. 10.1634/theoncologist.2017-0024
By:
- Benson, Al B.;
- Wainberg, Zev A.;
- Hecht, J. Randolph;
- Vyushkov, Dmitry;
- Dong, Hua;
- Bendell, Johanna;
- Kudrik, Fred
Publication type:
Article
A Phase II Randomized Trial (GO27827) of First-Line FOLFOX Plus Bevacizumab with orWithout the MET Inhibitor Onartuzumab in Patients with Metastatic Colorectal Cancer.
Published in:
Oncologist, 2017, v. 22, n. 3, p. 264, doi. 10.1634/theoncologist.2016-0223
By:
- Bendell, Johanna C.;
- Hochster, Howard;
- Hart, Lowell L.;
- Firdaus, Irfan;
- Mace, Joseph R.;
- McFarlane, Joshua J.;
- Kozloff, Mark;
- Catenacci, Daniel;
- Hsu, Jessie J.;
- Hack, Stephen P.;
- Shames, David S.;
- Phan, See‐Chun;
- Koeppen, Hartmut;
- Cohn, Allen L.
Publication type:
Article
Molecular Subtypes Improve Prognostic Value of International Metastatic Renal Cell Carcinoma Database Consortium Prognostic Model.
Published in:
Oncologist, 2017, v. 22, n. 3, p. 286, doi. 10.1634/theoncologist.2016-0078
By:
- de Velasco, Guillermo;
- Culhane, Aedín C.;
- Fay, André P.;
- Hakimi, A. Ari;
- Voss, Martin H.;
- Tannir, Nizar M.;
- Tamboli, Pheroze;
- Appleman, Leonard J.;
- Bellmunt, Joaquim;
- Kimryn Rathmell, W.;
- Albiges, Laurence;
- Hsieh, James J.;
- Heng, Daniel Y. C.;
- Signoretti, Sabina;
- Choueiri, Toni K.
Publication type:
Article